Live from ClinicalTrials.gov + Open Targets, fetched 2026-11-12 02:18 UTC. Every row links to its source record.
Postmortem · what the sponsor and named sources said, kept apart from what merely happened at the same time
Effect of PTH(1-34) Treatment on Fracture Healing in Vivo
NCT00741182 · Glostrup University Hospital, Copenhagen · PHASE2 · withdrawn · last registry update 2015-03-18 · Decision brief
No research has been run for this trial yet, so only the registry's own reason and the timeline are shown.
No reason was published
Stated is the sponsor's own words; Reported is a named third party. The category is our label from a fixed list; the quote is the evidence.
| Kind | Quote | Our category | Source |
|---|---|---|---|
| Stated | The registry record gives no reason | – | Registry record, Glostrup University Hospital, Copenhagen |
Also happening at the time. Not shown to be a cause.
Registry events on other trials of drugs against PTH1R within 12 months either side of this trial's last update, live from ClinicalTrials.gov. Nothing here was stated as a reason.
- 2016-02-24Results posted on the registry: University of Pittsburgh, Parathyroid hormone related protein (1-36) + Parathyroid hormone related protein(1-36) (NCT00853723)
- 2015-10-08Results posted on the registry: Eli Lilly and Company, Teriparatide + Denosumab (NCT01753856)
- 2015-09-23Also stopped (suspended): Medical University of Vienna, Denosumab + Teriparatide (NCT01734824)
- 2015-09-17Also stopped (withdrawn): Medical University of Vienna, Teriparatide + Placebo (NCT02091492)
- 2015-07-16Results posted on the registry: John P. Bilezikian, PTH (NCT00473265)
- 2015-06-25Results posted on the registry: University of California, Davis, Risedronate + Parathyroid Hormone (NCT00221299)
- 2014-12-22Results posted on the registry: Mayo Clinic, Teriparatide (NCT01171690)
- 2014-12-22Also stopped (terminated): Mayo Clinic, Teriparatide (NCT01171690)
- 2014-12-19Also stopped (terminated): University of Rochester, Teriparatide + Placebo (NCT00594906)
- 2014-11-17Results posted on the registry: Eli Lilly and Company, Teriparatide + Placebo (NCT01473602)
- 2014-11-17Results posted on the registry: Eli Lilly and Company, Teriparatide + Placebo (NCT01473589)
- 2014-10-29Also stopped (terminated): Papageorgiou General Hospital, ibandronate + teriparatide (NCT00446589)
- 2014-09-22Results posted on the registry: University of Wisconsin, Madison, Teriparatide + Raloxifene (NCT01166958)
- 2014-05-14Results posted on the registry: University of Maryland, Baltimore, Teriparatide (NCT00754442)
- 2014-03-19Phase 3 first posted: Medical University of Vienna, Teriparatide + Placebo (NCT02091492)
What is not public
- Internal portfolio and board discussions
- Unpublished trial data and interim analyses
- Terms of any partner or licence decision